[Pharmacological effects of butoxybenzyl hyoscyamine bromide on the motility and secretion of the gastrointestinal tract].
D000818:Animals; D001532:Atropa belladonna; D001285:Atropine / Q000494:pharmacology; D001593:Benzyl Compounds / Q000494:pharmacology; D001626:Bethanechol Compounds / Q000037:antagonists & inhibitors; D001646:Bile / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D003864:Depression, Chemical; D004064:Digestive System / Q000187:drug effects / Q000378:metabolism*; D004285:Dogs; D005260:Female; D005725:Ganglia, Autonomic / Q000187:drug effects; D005750:Gastric Juice / Q000378:metabolism; D005769:Gastrointestinal Motility / Q000187:drug effects*; D008297:Male; D051379:Mice; D009541:Nictitating Membrane / Q000187:drug effects; D010189:Pancreatic Juice / Q000378:metabolism; D010946:Plants, Medicinal; D010947:Plants, Toxic; D051381:Rats; D012463:Saliva / Q000378:metabolism; D012601:Scopolamine / Q000494:pharmacology; D013276:Stomach Ulcer / Q000188:drug therapy
D001593:Benzyl Compounds; D001626:Bethanechol Compounds; D001285:Atropine; D012601:Scopolamine